Log in | Register

Talk of Treaty Ban on Mercury Concerns Pharmaceutical Scientists

For the latest pharmaceutical news and updates - Sign up now!
Loading...

LONDON (AP) — Scientists are warning officials negotiating a global treaty on mercury that banning the deadly chemical completely would be dangerous for public health because of the chemical's use in vaccines.

The ban option is one of several proposals on the table for a meeting later this month in Nairobi, but a final treaty isn't expected until 2013.

According to the World Health Organization, mercury is one of the top 10 chemicals of public health concern and is highly toxic. Most of the worry is centered on mercury emissions from burning coal, gold mining and people eating mercury-tainted fish.

The problem is that a proposed ban might include thiomersal, a mercury compound used to prevent contamination and extend the shelf life of vaccines. It is used in about 300 million shots worldwide, against diseases including flu, tetanus, measles, diptheria and meningitis.

"Not being able to use mercury is not a viable option," said David Wood, a WHO vaccines expert.

Wood said there isn't a viable alternative to thiomersal at the moment. If banned, pharmaceuticals would likely have to switch to preservative-free vaccines, which would complicate the supply chain and vaccination campaigns in poor countries, since the injections would have a much shorter shelf life. Costs would also spike since manufacturers would need to reconfigure their factories.

In 2009, the United Nations Environment Programme, or UNEP, began working on a legally binding global treaty on mercury. At the end of October, the third of five meetings to hammer out a treaty will take place in Nairobi.

"The document is a draft at the moment, so some of these proposals have to be taken with a grain of salt," said Tim Kasten, head of the chemicals branch at UNEP. Kasten said the amount of mercury in vaccines is so minute it doesn't threaten the environment. He said there could be provisions to allow mercury for certain uses, such as in dental fillings and vaccines.

But according to an annex in the draft document, there is currently no "allowable use exemption" for mercury products in pharmaceutical products, putting vaccines in the same category as banned mercury-containing paints and pesticides.

"That would be a terrible idea," said Paul Offit, an infectious diseases expert at the University of Pennsylvania. "It would be another tragic example of us not being able to explain to the public where the real risk lies."

Thiomersal has mostly been removed from childhood vaccines in the U.S. and Canada. In some European countries, including Norway and Sweden, manufacturers have been encouraged to make thiomersal-free vaccines — and no other uses of mercury as a medical preservative are allowed.

Fears about thiomersal in vaccines were first raised after a flawed medical study in 1998 linked a common childhood injection to autism. But numerous studies since have found no sign the mercury compound is risky.

Experts hope countries won't go overboard in their attempts to control the substance.

"Provided you know the risks and it's handled properly, there isn't a problem," said Andrew Nelson, a toxicology expert at the University of Leeds. "The health of so many millions of children benefit from vaccines containing mercury that an absolute ban is ridiculous."

 

 

Join the Discussion
Rate Article:  Average 1 out of 5
register or log in to comment on this article!

3 Comments

  • (continued2) For a more complete rebuttal of the arguments raised here and an understanding of the toxicity of injected Thimerosal, the reader can read the recent documents published on http://mercury-freedrugs.org.

  • (continued) Apparently, no toxicologically “safe” level has been established for injected Thimerosal, where such would require the determination and publication of the appropriate no-observed-adverse-effect-level (NOAEL) such as those provide for other toxic chemicals.
    Based on the only FDA-recognized chronic toxicity study for injected Thimerosal in rats, the appropriate NOAEL for developing children is less than (<) 0.0086 micrograms of injected Thimerosal per kilogram of child weight on any given day (see: http://mercury-freedrugs.org/docs/090812_fnldrft_TheTruthAboutTheToxicityOfThimerosalr5b.pdf).
    Given that: a) the safe level (NOAEL for injected Thimerosal in children) is < 8.6 nanograms of Thimerosal per kg; b) young children’s weights of less than 10 kg; and c) the reality that typical Thimerosal-preserved vaccines contain nominally 100,000 nanograms of Thimerosal per milliliter of vaccine, even a 0.25-mL injection (delivering nominally 25,000 nanograms of Thimerosal) is much greater than (>>) 200 – 300 times the safe level for Thimerosal exposure in developing children.
    Thus, the unsupported statements made by the quoted toxicology expert:
    “‘Provided you know the risks and it's handled properly, there isn't a problem,’ said Andrew Nelson, a toxicology expert at the University of Leeds. ‘The health of so many millions of children benefit from vaccines containing mercury that an absolute ban is ridiculous’”,
    should be ignored because this expert obviously does not “know the risks”.
    Since the reduction of environmental mercury exposure is a critical need, it makes no sense to exempt a truly optional exposure source, particularly when many of the European and other developed countries have already “abandoned its use as a preservative in vaccines and other medicines” in the 1990s.
    For a more complete rebuttal of the arguments raised here and an understanding of the toxicity of injected Thimerosal, the reader can read the recent docume

  • This opposition to the continued unnecessary mercury-poisoning of pregnant women, babies, children and adults is not only illogical but also duplicitous.
    With respect to the passage:
    “The problem is that a proposed ban might include thiomersal, a mercury compound used to prevent contamination and extend the shelf life of vaccines. It is used in about 300 million shots worldwide, against diseases including flu, tetanus, measles, diptheria and meningitis”,
    as far as I can ascertain, a) Thimerosal/Thiomersal is only used “to prevent contamination” and, if anything, its use tends to shorten a vaccine’s shelf life; b) when Thimerosal/Thiomersal was added to the live-virus measles vaccines at a preservative level, it quickly killed the measles virus and rendered it unsuitable for use in a vaccine; and c) as far as I can ascertain, no live-virus vaccine contains a preservative level of Thimerosal/Thiomersal and most contain no preservative whatsoever.
    Further, the passage:
    "‘Not being able to use mercury is not a viable option,' said David Wood, a WHO vaccines expert.
    Wood said there isn't a viable alternative to thiomersal at the moment",
    is, at best, less -than-truthful because there are other chemicals that have been and are being used as preservatives (e.g., phenol and 2-phenoxy ethanol) in vaccines that are licensed in the USA, Europe, and elsewhere.
    Moreover, in an actual recent vaccine formulation, 2-phenoxyethanol has recently been again shown to be a superior preservative to Thimerosal/Thiomersal in Pfizer/Wyeth's recent Prevnar/Prevenar 13 vaccine formulation (Khandke L, Yang C, Krylova K, Jansen KU, Rashidbaig A. Preservative of choice for Prev(e)nar 13™ in a multi-dose formulation. Vaccine 2011, in press).
    When all of the costs are considered, including the costs of proper disposal of the residual Thimerosal-preserved vaccine as hazardous waste, 2-phenoxyethanol is cost competitive and much less toxic than Thimerosal/Thiomersal.

Add Comment

Text Only 2000 character limit

Page 1 of 1

Blogs

The Tale of Two Deviations

The Tale of Two Deviations

Apr 23 | The QA Pharm

It stands to reason that pharmaceutical companies in compliance trouble also have problems with their Deviation Management and Corrective and Preventive Action (CAPA) System(s).

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Apr 16 | Girish Malhotra, PE, President, EPCOT International

The answer is an unequivocal yes but we need some outsiders who can conspire with the insiders who will be the flag bearers within the companies. Outsiders can be the counsels/co-conspirators to the insiders for the coup d'etat.

Multimedia

Lung Cancer Drug Treats Rare Lymphoma Tumors

Lung Cancer Drug Treats Rare Lymphoma Tumors

May 17 | Video

A new study found Xalkori effective in treating anaplastic lymphoma among children, an encouraging development for gene-targeted therapy.

Merck - 2012 Facility of the Year Award - Facility Integration

Merck - 2012 Facility of the Year Award - Facility Integration

May 14 | Video

Brian Morrissey, Senior Project Engineer, Merck Manufacturing Division, talks to Pharmaceutical Processing's Editor In Chief Mike Auerbach during INTERPHEX 2012 about the company's Vaccine Bulk Manufacturing Facility Program of Projects. The facility has won the Facility Integration award in the 2012 Facility of the Year Award competition sponsored by ISPE, INTERPHEX and Pharmaceutical Processing magazine.

Medicine from a Vending Machine?

Medicine from a Vending Machine?

May 3 | Video

A Chinese company is pushing for acceptance of traditional Chinese medicine with a machine that can dispense herbs.

Taking Precautions to Prevent Contagion

Taking Precautions to Prevent Contagion

Apr 29 | Video

With the recent outbreak of viruses such as SARS, bird flu and swine flu, officials and travelers are being extra careful about preventing the illnesses from being transmitted.

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter